The Latin America, Middle East and Africa Extremity Reconstruction Market is expected to witness market growth of 9.8% CAGR during the forecast period (2022-2028).
Only until the vascular injury has been handled and corrected, bone fixation has been completed, and all polluted and necrotic tissue has been debrided, then, a traumatic lower extremity can be rebuilt. The fundamental principle of debridement of all necrotic tissue is critical to the final success of any reconstruction, and it frequently necessitates multiple operative debridements before final wound coverage.
Sarcomas are the most common malignant tumors that arise from the skeleton and affect the tibia. Lower-extremity tumors are frequently treated with limb-sparing procedures, which involve excision of the tumor and adjuvant radiation therapy. When contrasted to amputation, the treatment regimen has resulted in equal disease-free survival rates and has typically allowed for superior functional outcomes. Extremity reconstruction is an important component of limb-saving surgery after large radical resections and irradiation. Resection of a tumor with margins frequently leaves enormous defects that are difficult to seal and expose tendon, bone, or neurovascular structures. Irradiation causes wound closure even more challenging, increasing the risk of chronic and acute wound problems. As a result, the role of plastic surgery in the treatment of individuals is important.
Every year, vehicle accidents result in a considerable amount of fatalities and deaths in LAMEA region. The need of extremity reconstruction system is increasing due to a growth in the frequency of accidents, as well as diabetes and other chronic illnesses. For instance, according to the National Library of Medicine, population growth and ageing will result in a substantial increase in new cancer cases by 2030. This chronic illness has coexisted with newly found communicable diseases in Africa, including AIDS, Malaria, Ebola, and COVID-19. Melanoma is also extremely common in South Africa, according to the organization. In 2017, this cancer afflicted 15% of the population of the country. The number of procedures in the region is probable to rise in the coming years as cancer rates continue to rise.
The Brazil market dominated the LAMEA Extremity Reconstruction Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $102.3 Million by 2028. The Argentina market is poised to grow at a CAGR of 10.4% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 9.5% during (2022 - 2028).
Based on Material, the market is segmented into Metallic, Ceramic, Polymeric, and Natural. Based on Product, the market is segmented into Upper Extremity and Lower Extremity. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), Integra LifeSciences Holdings Corporation, Medtronic PLC, ConMed Corporation, Acumed LLC, Skeletal Dynamics, LLC, Arthrex, Inc., and IDS GeoRadar s.r.l.(Hexagon AB)
Only until the vascular injury has been handled and corrected, bone fixation has been completed, and all polluted and necrotic tissue has been debrided, then, a traumatic lower extremity can be rebuilt. The fundamental principle of debridement of all necrotic tissue is critical to the final success of any reconstruction, and it frequently necessitates multiple operative debridements before final wound coverage.
Sarcomas are the most common malignant tumors that arise from the skeleton and affect the tibia. Lower-extremity tumors are frequently treated with limb-sparing procedures, which involve excision of the tumor and adjuvant radiation therapy. When contrasted to amputation, the treatment regimen has resulted in equal disease-free survival rates and has typically allowed for superior functional outcomes. Extremity reconstruction is an important component of limb-saving surgery after large radical resections and irradiation. Resection of a tumor with margins frequently leaves enormous defects that are difficult to seal and expose tendon, bone, or neurovascular structures. Irradiation causes wound closure even more challenging, increasing the risk of chronic and acute wound problems. As a result, the role of plastic surgery in the treatment of individuals is important.
Every year, vehicle accidents result in a considerable amount of fatalities and deaths in LAMEA region. The need of extremity reconstruction system is increasing due to a growth in the frequency of accidents, as well as diabetes and other chronic illnesses. For instance, according to the National Library of Medicine, population growth and ageing will result in a substantial increase in new cancer cases by 2030. This chronic illness has coexisted with newly found communicable diseases in Africa, including AIDS, Malaria, Ebola, and COVID-19. Melanoma is also extremely common in South Africa, according to the organization. In 2017, this cancer afflicted 15% of the population of the country. The number of procedures in the region is probable to rise in the coming years as cancer rates continue to rise.
The Brazil market dominated the LAMEA Extremity Reconstruction Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $102.3 Million by 2028. The Argentina market is poised to grow at a CAGR of 10.4% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 9.5% during (2022 - 2028).
Based on Material, the market is segmented into Metallic, Ceramic, Polymeric, and Natural. Based on Product, the market is segmented into Upper Extremity and Lower Extremity. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), Integra LifeSciences Holdings Corporation, Medtronic PLC, ConMed Corporation, Acumed LLC, Skeletal Dynamics, LLC, Arthrex, Inc., and IDS GeoRadar s.r.l.(Hexagon AB)
Scope of the Study
Market Segments Covered in the Report:
By Material
- Metallic
- Ceramic
- Polymeric
- Natural
By Product
- Upper Extremity
- Lower Extremity
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Smith & Nephew PLC
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Johnson & Johnson (DePuy Synthes)
- Integra LifeSciences Holdings Corporation
- Medtronic PLC
- ConMed Corporation
- Acumed LLC
- Skeletal Dynamics, LLC
- Arthrex, Inc
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Extremity Reconstruction Market by Material
Chapter 5. LAMEA Extremity Reconstruction Market by Product
Chapter 6. LAMEA Extremity Reconstruction Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Smith & Nephew PLC
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Johnson & Johnson (DePuy Synthes)
- Integra LifeSciences Holdings Corporation
- Medtronic PLC
- ConMed Corporation
- Acumed LLC
- Skeletal Dynamics, LLC
- Arthrex, Inc.
Methodology
LOADING...
